Machines and Molecules – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Machines and Molecules

Science

Frequency: 1 episode/49d. Total Eps: 20

Machines and Molecules hosts guests on topics from machine learning as well as bio-chemistry/biotech, and therefore bridges the gap between those worlds. The podcast covers three different categories - Knowledge, Solution and Network. Knowledge offers tutorials regarding fundamental concepts within the ML and biochem realm, Solution spotlights companies and startups implementing AI in life sciences or building AI infrastructure, and Network deep dives into investment, politics, and industry networks within this sector. The podcast is hosted by Exazyme, the AI powered protein design platform.

Read moreCollapse

Site

RSS

Apple

Data updated on 04/07/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

No links shared by this podcast

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 53%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Automating Scientific Discovery with MIT Professor Markus J. Buehler

Season 3 · Episode 2

Thursday, February 26, 2026 • Duration 43:53

In this episode of the Machines and Molecules podcast, host Marcus Bühler, the McAfee Professor of Engineering at MIT, discusses the principle of "adaptability" as the most important universal principle of materials for newcomers to absorb. His work focuses on bridging atomistic simulation, multiscale mechanics, and AI-driven materials design, aiming to automate the scientific process. He explains how biological systems, like spider silk and bone, have a built-in ability to change and adapt over time.

The conversation explores the limitations of brute-force molecular dynamics (MD) simulations and the shift toward using smarter, goal-directed computational experiments. Bühler details his lab's use of category theory to model the discovery process and train AI agents to find universal principles, create new hypotheses, and automate scientific research.

Finally, we chat about the connections between music, sound, and the material world, which informs his work in AI and the search for unifying theories.

Read moreCollapse

Chris Bahl on the Conundrum of Biotech Platforms

Season 3 · Episode 1

Friday, November 21, 2025 • Duration 33:40

Chris Bahl is founder and CEO of AI Proteins. The conversation delves into the challenges faced by platform companies in the biotech sector, highlighting the financial pressures that lead to the cutting of innovative projects. It discusses how investors prioritize immediate monetization of assets over long-term development, often resulting in the abandonment of potentially successful platforms.

Takeaways

It's tough out there in the world today to be a platform company.

The fate of most platforms in biotech is that it's a cool engine.

Investors want to monetize that asset.

Hundreds of millions of dollars are needed to get products across the finish line.

Investors are not interested in products that are 10 years away.

Platforms often become line items that get cut from budgets.

Many great platforms are effectively thrown in the trash.

Successful platforms are often discarded due to financial pressures.

Monetization is key for biotech platforms.

Innovation struggles under financial constraints.

Read moreCollapse

Pioneering Molecular Modeling: Victor Guallar’s Insights on Monte Carlo, AI, and Biophysics

Season 2 · Episode 8

Wednesday, December 11, 2024 • Duration 32:35

Victor Guallar is an ICREA Professor and group leader of the EAPM at the Barcelona Supercomputing Center and Co-Founder of Nostrum Biodiscovery. With a joint PhD from the Autonomous University of Barcelona and UC Berkeley, followed by roles at Columbia University and Washington University, he has built extensive expertise in molecular modeling, enzyme engineering, and drug discovery. At the Barcelona Supercomputing Center, he leads the Atomic and Electronic Protein Modeling group, where his work integrates advanced simulations, machine learning, and quantum mechanics to solve challenges in biophysics and sustainability. Victor’s contributions have resulted in over 120 peer-reviewed publications and recognition through prestigious grants, including the ERC Advanced Grant. In this episode of Machines and Molecules, Victor shares his expertise in leveraging Monte Carlo simulations for protein discovery and optimization. Victor explains the value of simulations in molecular science, detailing how they generate data to predict molecular behavior and improve drug discovery, enzyme engineering, and material science. He contrasts Monte Carlo and molecular dynamics methods, emphasizing their respective strengths and his advancements in creating more efficient simulation tools. Victor also discusses the synergy between simulations and AI, highlighting how combining virtual data with machine learning accelerates innovation and improves accuracy. Drawing from his dual roles in academia and industry, he reflects on the disconnect between academic research and industry needs, advocating for practical applications that make scientific work more impactful. The conversation concludes with insights into the benefits of multidisciplinarity, as Victor shares how diverse interests and experiences have shaped his creativity and career. 00:00 - 01:13 Introduction to Victor Guallar 01:13 - 05:57 Molecular Simulations and Their Applications 05:57 - 10:30 Monte Carlo vs. Molecular Dynamics 10:30 - 13:32 How Simulations Generate Data and Integrate with AI 13:32 - 16:56 Sampling vs. Optimization 16:56 - 20:35 The Role of AI in Molecular Modeling 20:35 - 25:30 Applications of Virtual Data in Drug Discovery & Protein Design 25:30 - 31:00 Victor’s 3rd M Word Category: Knowledge

Building Bridges in Biotech: Markus Müller on CLIB’s Role in Creating a Collaborative and Connected Bioeconomy

Season 2 · Episode 7

Tuesday, November 5, 2024 • Duration 35:11

Markus Müller is an experienced project manager with expertise in biotechnology and bioeconomy, focused on bridging research and industry to advance sustainable bioprocesses. As Project Manager at CLIB – Cluster Industrial Biotechnology, he oversees collaborative initiatives that support innovation across academia and industry. Previously, Markus led the Bio² project at RWTH Aachen University, integrating advanced biosurfactant production into biorefinery processes. With a Master’s in Molecular and Applied Biotechnology and a background in enzyme development, Markus is dedicated to fostering efficient, impactful biotechnological solutions.

In this episode of Machines and Molecules, Markus Müller, Project Manager at CLIB – Cluster Industrial Biotechnology, explains the value of cluster organizations in advancing biotechnology by connecting industry players and researchers. Markus emphasizes that CLIB differs from traditional industry groups by acting as a neutral mediator, fostering collaboration rather than lobbying. Key challenges discussed include the difficulty of integrating biotech and AI into established industries, especially due to communication gaps between technical and non-technical stakeholders. Markus highlights biotechnology's role in creating sustainable alternatives to fossil-based processes, such as renewable bio-based plastics, while also addressing the bioeconomy’s potential for recycling and waste reduction. The conversation concludes with insights into effective strategies for bridging gaps between scientific advancements and policy decisions, aiming to create a supportive regulatory environment for biotechnological innovation.

00:00 - 02:30 Introduction to Markus Müller and CLIB

02:30 - 06:15 The Role of Cluster Organizations in Advancing Biotechnology

06:15 - 10:00 How CLIB Differentiates Itself as a Neutral Mediator

10:00 - 15:20 The need for Bioeconomy and differences to Chemistry

15:20 - 20:00 Trends in Biotech Industry / Bioeconomy

20:00 - 23:38 Communicating Complex Scientific Ideas to Policymakers

Accelerating AI Innovation: Laura Möller’s Mission to Shape the Startup Ecosystem and Foster Entrepreneurship in Academia.

Season 2 · Episode 6

Thursday, October 10, 2024 • Duration 33:42

Laura Möller is a seasoned expert in venture capital and entrepreneurship, with a focus on artificial intelligence and technology transfer. She holds leadership roles as Director of the Künstliche Intelligenz Entrepreneurship Zentrum (K.I.E.Z.) and UNITE in Berlin, and is the founder of Paola Ventures. With over a decade of experience, she has built expertise in supporting start-ups and fostering innovation in AI-driven ventures. She holds a Master’s degree in European Studies from Humboldt-Universität. Laura’s broad network and hands-on experience make her a vital asset in connecting entrepreneurs and investors, advancing Berlin’s tech ecosystem.

In this episode of Machines and Molecules, Laura Möller, Director of KIEZ Accelerator, discusses supporting AI-driven startups, particularly those rooted in scientific research. She highlights KIEZ’s individualized approach, offering startups access to a strong network of venture capitalists, grants, and expert guidance. Laura emphasizes the challenge for AI and science-based startups in turning cutting-edge technology into practical business solutions.She also shares KIEZ’s vision of uniting accelerators and networks to create interdisciplinary teams of AI and domain experts and bridge gaps between research and commercialization. Laura stresses the need to open the funnel and fully utilize the potential of all researchers in academia, not just those who choose the entrepreneurial path. Laura believes fostering entrepreneurial education early, would be a gamechanger to the European startup ecosystem.

00:00 - 03:40 Introduction to Laura Möller and KIEZ Accelerator

03:40 - 05:45 Individualized Support Offered by KIEZ to Startups

05:45 - 07:40 Long-term Vision of KIEZ

07:40 - 10:45 Common Challenges Faced by AI and Science-Based Startups

10:45 - 15:22 Strategies for Securing Funding After the KIEZ Accelerator

15:22 - 19:50 Enhancing Access to Government Funding in the EU

19:50 - 28:50 Comparison of EU and US Funding and other Factors for Startup Success

Productizing Research Code: Martin Steinegger on how to create useful and reusable Software

Season 2 · Episode 5

Friday, September 6, 2024 • Duration 33:47

Dr. Martin Steinegger is an expert in computational biology and bioinformatics, specializing in large-scale sequence data analysis. He earned his Ph.D. from the Technical University of Munich in collaboration with the Max Planck Institute for Biophysical Chemistry, focusing on methods to cluster and assemble metagenomic sequencing data. Currently an Associate Professor at Seoul National University, his research group develops novel computational methods to analyze microbial communities using machine learning and big data algorithms. Martin is the creator of MMseqs, a highly efficient software suite for protein sequence searches and co-author of AlphaFold2. His work in pathogen detection and metagenomics has made a significant impact on bioinformatics, with a strong commitment to open science and open-source tools.

Together with Martin we discuss the importance of productizing research code and the key factors for creating reusable software. He emphasizes the need for user-friendly interfaces, intuitive outputs, and software that doesn't crash. Martin talks about his background in software engineering and how it influenced his approach to developing tools in bioinformatics. Hence, he gives an overview about all the different tools he has developed over the years and for what they are used. Furthermore, he explains the significance of protein structure in understanding protein evolution and function, and highlights the role of his tools MMSeqs and AlphaFold in protein sequence and structure analysis. Martin shares his personal journey from starting in a lower-level school to pursuing higher education and research, driven by his passion for computers and learning.

00:00 - 01:32 Introduction

01:32 - 06:25 Productization of research code

06:25 - 08:20 Testing of software

08:20 - 12:28 Overview about the tools Martin has developed

12:28 - 15:40 The relevance of protein structure

15:40 - 18:00 Structural vs. Statistical approaches

Driving Innovation Forward: Carlos Härtel on Deep Tech Solutions and Market Adoption

Season 2 · Episode 4

Monday, July 29, 2024 • Duration 34:54

In this episode we host Carlos Härtel, an expert in innovation and strategy within the applied sciences. Carlos holds a Habilitation in Mechanical Engineering from ETH Zürich and a PhD in Chemical Engineering from the Technical University of Munich. Currently, he is a Venture Partner at Spacewalk VC, investing in deep tech startups, and a Senior Advisor at Carbon Removal Partners, focusing on carbon withdrawal technologies. He also chairs the Board at Science|Business, fostering collaboration between industry, research, and policy. Previously, Carlos served as CTO at Climeworks, a leader in carbon dioxide air capture technology, and held significant roles at General Electric, including CTO and Chief Innovation Officer for Europe. Additionally, he was a Non-Executive Director at Futurice, a digital consultancy, and Chairman at EUROGIA2020, promoting low-carbon energy technologies.

Carlos joins us in our Ecosystem category. We dive into CO2 capturing technologies and their role in climate innovation. Key takeaways include the cost-effectiveness of capturing CO2 at industrial sources, the advanced direct air capture methods Carlos developed at Climeworks, and the challenges of ocean-based CO2 capture. Drawing from his experience, Carlos furthermore discusses the critical factors for advancing hard technical innovations in climate and deep tech. He highlights how market demand drives innovation, addresses the chicken-and-egg dilemma of reliability versus adoption, and emphasizes the role of government policies in creating market demand. His insights reveal what’s needed to overcome barriers and implement complex solutions effectively.

Read moreCollapse

AI Meets Protein Science: Dr. Stanislav Mazurenko on the Impact of Machine Learning in Protein Engineering

Season 2 · Episode 3

Thursday, July 4, 2024 • Duration 36:14

In this episode, we are excited to host Dr. Stanislav Mazurenko, a leading expert in protein engineering and artificial intelligence. With a Ph.D. in applied mathematics and cybernetics from Lomonosov Moscow State University and extensive postdoctoral research at Loschmidt Laboratories, Stanislav now leads research at RECETOX. We delve into molecular dynamics simulations, statistical models, and the application of machine learning to protein design. Key takeaways include the essential role of proteins, the complexities of simulating their dynamics, and the optimization benefits provided by machine learning. Stanislav highlights the synergy between automation and machine learning, and underscores the importance of learning from mistakes in scientific research.

Read moreCollapse

From Molecular Dynamics to Bayesian Optimization: Matteo Aldeghi on Cutting-Edge Molecular Design

Season 2 · Episode 2

Wednesday, June 12, 2024 • Duration 39:25

In this episode, we're joined by Matteo Aldegni, Director of Machine Learning Research at Bayer, where he leads a team specializing in Machine Learning applications for chemistry and drug discovery. Matteo delves into the intricacies of Molecular Dynamics, the cornerstone of computer-aided molecular design, shedding light on how it paved the way for modern Machine Learning techniques. From the innovative sampling methods inspired by Molecular Dynamics to the transformative potential of Bayesian optimization, Matteo provides insights into the cutting-edge advancements driving molecular design. Join us as we explore the intersection of first-principles molecular models and Machine Learning, as well as Matteo's vision for the future of molecular design, including the concept of self-driving laboratories and Machine Learning force fields.

Read moreCollapse

Unlocking AI Success: Insights from Richard Socher on Startup Building and Investment Strategies

Season 2 · Episode 1

Thursday, May 23, 2024 • Duration 29:34

In this episode, we welcomed Richard Socher, AI expert and serial entrepreneur, serving as CEO and founder of you.com, a pioneering chat-search assistant, and as founder and managing partner of AIX Ventures, guiding and supporting AI startups. Focusing on this wealth of experience, we delved into the core drivers of AI startup success and investment strategies. Richard emphasized AI's versatility, its seamless integration across diverse use cases, and its immense potential, distinguishing it from other ventures and technologies. Regarding the paramount aspects of startup building and investment decisions, he stressed the importance of assembling top talent, maintaining focus, and avoiding overextension. Having a solid Plan A and a thoughtful approach to pivoting if needed are crucial for success.

Read moreCollapse

Machines and Molecules – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Machines and Molecules – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify